SCHEMBL23981

SCHEMBL23981

[c]1c2ccccc2nc2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.56
KDM4E B2RXH2 7/20 0.46
ALDH1A1 P00352 6/20 0.46
HPGD P15428 5/20 0.46
GLA P06280 4/20 0.46
NQO2 P16083 4/20 0.46
HSD17B10 Q99714 3/20 0.46
MAOA P21397 2/20 0.46
ACHE P22303 2/20 0.46
CASP1 P29466 2/20 0.46
CASP7 P55210 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
CHRM2 P08172 1/20 0.46
ADRA2A P08913 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
CHRM1 P11229 1/20 0.46
DRD1 P21728 1/20 0.46
SLC6A2 P23975 1/20 0.46
ADRA1A P35348 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4078572 0.82 MAPT (0.39) MAPTKDM4EALDH1A1HPGDGLA
SCHEMBL3946249 0.82 CLK1 (0.40) MAPTKDM4EALDH1A1HPGDGLA
SCHEMBL1663602 0.78 MAPT (0.39) MAPTKDM4EALDH1A1HPGDGLA
SCHEMBL9343254 0.77 PDE10A (0.39) ALDH1A1NQO2SMN1; SMN2KCNH2RAB9A
SCHEMBL5441553 0.76 MAPT (0.37) MAPTKDM4EALDH1A1HPGDGLA
SCHEMBL18317351 0.76 NQO2 (0.42) MAPTKDM4EALDH1A1HPGDGLA
SCHEMBL3442515 0.76 ACHE (0.57) MAPTKDM4EALDH1A1HPGDNQO2
SCHEMBL12474833 0.76 CYP3A4 (0.41) MAPTKDM4EALDH1A1HPGDGLA
SCHEMBL270509 0.76 MAPT (0.36) MAPTKDM4EALDH1A1HPGDGLA
SCHEMBL4755878 0.76 GPR3 (0.48) MAPTKDM4EALDH1A1HPGDNQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 13448 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239824-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2024-07-18 US claimed
US-20240244858-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2024-07-18 US claimed
US-20240244953-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2024-07-18 US claimed
CN-118344396-A Carbazole compound, intermediate and organic electroluminescent device 阜阳欣奕华材料科技有限公司 2024-07-16 CN claimed
CN-110400884-B Organic light emitting device and method of manufacturing the same 三星显示有限公司 2024-07-12 CN claimed
CN-118324771-A Organic light-emitting device, electronic device, and heterocyclic compound 三星显示有限公司 2024-07-12 CN claimed
US-20240237507-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO LTD (KR) 2024-07-11 US claimed
CN-118317622-A Light-emitting device, electronic apparatus, electronic device, and organometallic compound 三星显示有限公司 2024-07-09 CN claimed
CN-118290485-A Organometallic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device 三星电子株式会社 2024-07-05 CN claimed
CN-118290494-A Organometallic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device 三星电子株式会社 2024-07-05 CN claimed
EP-0676958-A1 METHOD FOR INHIBITING INTRACELLULAR VIRAL REPLICATION CELL THERAPEUTICS, INC. (US) 1995-10-18 EP claimed
WO-1995026347-A1 THIAZOLIDINES AND OXAZOLIDINES SUBSTITUTED BY A PYRIDINE RING AND THEIR USE AS HYPOGLYCEMIC AGENTS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1995-10-05 WO claimed
WO-1995019171-A1 METHOD FOR TREATING DISEASES MEDIATED BY CELLULAR PROLIFERATION IN RESPONSE TO PDGF, EGF, FGF AND VEGF CELL THERAPEUTICS, INC. (US) 1995-07-20 WO claimed
WO-1995013075-A1 METHOD FOR PREVENTING TISSUE INJURY FROM HYPOXIA CELL THERAPEUTICS, INC. (US) 1995-05-18 WO claimed
WO-1995012396-A1 METHOD FOR INHIBITING INTRACELLULAR VIRAL REPLICATION CELL THERAPEUTICS, INC. (US) 1995-05-11 WO claimed
EP-0252476-B1 Trans-6-[2-(N-heteroaryl-3,5-disubstituted) pyrazol-4-yl)-ethyl]- or ethenyl] tetrahydro-4-hydroxypyran-2-one-derivatives a process for their preparation and the use thereof WARNER LAMBERT CO (US) 1994-02-02 EP claimed
EP-0167820-B1 PROCESS FOR THE PREPARATION OF OPTIONALLY SUBSTITUTED BENZ(C,D)-INDOL-2-ONES (NAPHTHOLACTAMES) BAYER AG (DE) 1989-04-26 EP claimed
EP-0252476-A2 Trans-6-[2-(N-heteroaryl-3,5-disubstituted) pyrazol-4-yl)-ethyl]- or ethenyl] tetrahydro-4-hydroxypyran-2-one-derivatives a process for their preparation and the use thereof WARNER-LAMBERT COMPANY (US) 1988-01-13 EP claimed
US-4618686-A INCLUDES POLYCHLORINATED BIPHENYLS AND DIBENZO-P-DIOXINS; PALLADIUM CATALYST AND PHYPOPHOSPHITE CIBA-GEIGY CORPORATION (US) 1986-10-21 US claimed
EP-0046164-B1 UTILISATION OF PERYLENE DERIVATIVES FOR PURPOSES OF FLUORESCENCE AND NOVEL PERYLENE DERIVATIVES FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) 1983-11-30 EP claimed